As an example, HER2+ breast cancer typically expresses LIN28A, while triple negative breast cancer is LIN28B (Piskounova et al., 2011; Yang J. et al., 2015; Shen et al., 2016). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.